Table 1.
Patient characteristics
| Variables | Control Group (IPSS < 8) n = 20 |
LUTS Group (IPSS ≥ 8) n = 63 |
P-value |
|---|---|---|---|
| Age (years) | 63.4 (7.1) | 64.4 (6.3) | 0.546 |
| IPSS, mean (SD) | 4.3 (2.5) | 18.3 (5.5) | < 0.001 |
| ASA Classification, n (%) |
1: 14 (70%) 2: 5 (25%) 3: 1 (5%) |
1: 21 (33.3%) 2: 39 (61.9%) 3: 3 (4.8%) |
0.013 |
| Charlson Index, n (%) |
0: 13 (65%) 1: 6 (30%) 2: 1 (5%) |
0: 43 (68.3%) 1: 13 (20.6%) 2: 7 (11.1%) |
0.807 |
| Prostate Volume (cm3), mean (SD) | 56.7 (28.4) | 52.1 (22.6) | 0.466 |
| Residual Urine (ml), mean (SD) | 81.6 (36.2) | 101.7 (131.8) | 0.573 |
| Q-max (ml/sec), mean (SD) | 17.7 (11.4) | 15.8 (8.8) | 0.475 |
| PSA (µg/L). mean (SD) | 3.5 (3.4) | 3.1 (3) | 0.608 |
| BMI (kg/m2), mean (SD) | 26.9 (3.2) | 27.3 (4) | 0.710 |
Note: IPSS: International Prostatic Symptom Score, LUTS: Lower urinary tract symptoms, ASA: American Society of Anestesiology, PSA: Prostatic Specific Antigen, BMI: Body Mass Index.